9;effect intervent avail prevent hiv women target intervent requir understand risk acquir hiv use surveil data estim risk hiv acquisit 13 59 year old women follow diagnosi syphili gonorrhoea chlamydia florida 2000 2009 exclud women report hiv sti measur hiv report subsequ sti 2011 rate compar women report sti total 328 456 women syphili 3325 gonorrhoea 67 784 chlamydia 257 347 2 221 944 person year follow up 2118 diagnos hiv women sti report 64 763 832 person year 19 531 report hiv crude rate subsequ hiv diagnosi 100 000 person year higher women diagnos syphili 597 9 gonorrhoea 171 3 chlamydia 66 3 women sti 30 2 annual rate hiv decreas over al 61 8 2001 2011 women syphili gonorrhoea highest risk hiv benefit intens counsel repres small fraction women acquir hiv case hiv infect women occur larg group women highest risk
13;studi investig effect handl stabil maximum push pul forc hypothes peopl appli forc direct deviat pure push pul direct gener moment assist produc greater push pul forc handl posit fix stabl compar fix unstabl healthi subject perform maximum push pull exert stabl unstabl handl seat postur maximum push pul forc vertic forc later forc record unstabl handl vertic later forc differ zero push pull stabl handl subject intuit appli signific downward forc push signific upward forc pull exert predict biomechan analysi downward upward forc significantli associ increas push pull forc respect stabl handl compar unstabl handl
18;investig associ perceiv everyday discrimin psycholog distress urban african american women young children 6 year live low incom neighborhood specif examin instrument emot social support moder associ perceiv everyday discrimin psycholog distress data come detroit dental health project two stag area probabl sampl repres low incom african american children citi detroit analysi focus 969 femal caregiv young children seri hierarch regress analys perform examin role social support link perceiv everyday discrimin psycholog distress appropri adjust complex sampl design moder high frequenc level discrimin associ higher level psycholog distress control age educ incom self rat health main effect emot support avail emot support associ psycholog distress instrument support exert buffer effect mitig neg influenc moder level perceiv discrimin psycholog distress find suggest instrument social support provid protect everyday stress social support doe offset impact acut stress caus frequent percept everyday discrimin
19;kilimanjaro region highest rate report alcohol use capita tanzania alcohol rel riski behavior pose substanti threat health well b alcohol user peopl studi seek understand alcohol rel riski behavior co occur riski behavior latent class analysi lca appli examin alcohol rel riski behavior optim number latent class confirm use model fit indic neg binomi model use test latent class associ harm hazard drink perceiv alcohol stigma model defin explor class s drink pattern riski behavior pattern total 622 60 male 841 particip includ analys drank alcohol lifetim class riski behavior pattern identifi class 1 limit risk behavior 59 7 class 2 primarili foolish behavior 25 6 class 3 pervas risk behavior 13 1 class 3 alcohol use quantiti frequenc associ class alcohol stigma compar male femal like classifi class 2 3 differ class riski behavior appar distinguish gender age person alcohol use find suggest potenti role person intervent base latent class specif reduc risk behavior
45;issu oxytocin natur hormon caus uteru womb regular pain contract labour start avail intraven vein iv drug infus slowli artifici stimul labour doctor midwiv feel necessari acceler birth babi mother request western countri pregnant women labour induc usual prostaglandin drug combin oxytocin risk associ use iv oxytocin stimul uterin contract includ woman have contract long frequent uterin hyperstimul lead chang babi s heart rate need emerg caesarean review examin stop iv oxytocin labour well establish i e cervix dilat halfway reduc associ risk mother babi compar continu iv oxytocin import stop oxytocin infus activ labour start result natur childbirth particularli risk uterin overstimul need immedi caesarean section reduc overal total dose oxytocin mother receiv reduc lead fewer advers effect e g matern nausea vomit headach chang babi s heart rate evid did search evid januari 2018 10 randomis control studi 1888 women babi conduct februari 1998 januari 2016 hospit denmark greec turkey israel iran usa bangladesh india thailand confid result studi design limit find report stop iv oxytocin activ labour reduc number women caesarean section trial 1784 women perform analysi includ women actual activ labour probabl littl differ group trial 787 women discontinu iv oxytocin probabl reduc risk women have contract long strong result chang babi s heart rate trial 486 women uncertain stop iv oxytocin affect risk have bacteri infect membran sac insid womb trial 252 women stop iv oxytocin labour littl impact women s use analgesia epidur compar women continu receiv iv oxytocin trial 556 women probabl fewer babi discontinu iv oxytocin group abnorm cardiotocographi result electron method measur women s contract babi s heartbeat compar women continu receiv iv oxytocin seven trial 1390 women compar continu iv oxytocin discontinu iv oxytocin probabl littl impact number babi low score standard test well b newborn babi apgar minut born trial 893 women measur infant well b involv analys blood taken umbil cord trial 873 women includ trial did report review s outcom includ death mother babi doe mean stop oxytocin activ phase labour start reduc number women contract long strong result chang babi s heart rate risk have caesarean possibl reduct risk caesarean artefact poor studi design better qualiti trial need includ analysi women did reach activ phase labour babi deliv earlier caesarean labour rapid oxytocin stop time i e analysi intention to treat futur studi includ outcom list review includ women s satisfact
48;e1 glycoprotein mr 26 014 228 amino acid mous hepat viru a59 class iii membran glycoprotein use studi model studi membran integr protein transport protein lack nh2 termin cleavabl signal sequenc span viral membran time hydrophob domain iii serv signal sequenc cotransl membran integr domain suffici transloc hydrophil nh2 terminu e1 membran evidenc glycosyl newli introduc n glycosyl site cooh termin e1 involv amino acid leu124 thr228 associ tightli membran post transl level molecul lack pronounc hydrophob sequenc membran protect assay proteinas k show 2 kda hydrophil fragment remov cooh terminu e1 indic protein larg embed membran microinject vitro transcrib cap polyadenyl mrna cv 1 cell secretori att20 pituitari tumor cell show e1 protein accumul golgi detect plasma membran secretori granul 28 nh2 termin hydrophil amino acid residu play role membran assembl intracellular target variou nh2 termin portion e1 fuse ile145 cytoplasm n protein mous hepat viru result hybrid protein shown assembl membran vitro detect rough endoplasm reticulum transient vesicl microinject cell
50;increas focu late function effect head neck cancer hnc treatment studi undertaken evalu incid late proxim esophag strictur patient undergo total laryngectomi tl radiat therapi rt institut retrospect review hnc patient treat 1995 2003 tl rt undertaken thirty thre patient stage ii iv diseas includ 25 patient tl postop rt group 1 8 patient definit rt salvag laryngectomi group 2 median follow up 28 month follow up 25 patient 76 aliv diseas free die 3 develop distant metastasi dysphagia stenosi develop 40 group 1 75 group 2 patient median time dysphagia 5 5 month patient incid esophag stenosi 33 patient contribut factor esophag stenosi tl rt includ continu alcohol tobacco use dose volum relationship rt normal tissu damag tumor treatment
